Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …

Neurodegenerative disorders (NDs) such as Alzheimer's disease, Parkinson's disease,
Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis are severe and …

Cannabidiol is popularly known as CBD, a substance that is part of the cannabinoids,
chemical components extracted from the cannabis or hemp plant. Of all the chemical …

Cannabis sativa, a versatile plant with numerous varieties, holds promising potential for a
wide range of biological activity. As raw materials for research, we chose leaves and …

The term extrapyramidal disorders is most often used for conditions such as Parkinson's
disease or Huntington's disease, but also refers to a group of extrapyramidal side effects of …

Endocannabinoids were implicated in a variety of pathological conditions including anxiety
and are considered promising new targets for anxiolytic drug development. The optimism …

Background The NLRP3 inflammasome is a vital player in the emergence of inflammation.
The priming and activation of the NLRP3 inflammasome is a major trigger for inflammation …

Introduction The involvement of endocannabinoid system (ECS) in the inflammatory
cascade, and the ability of phytocannabinoids, endocannabinoids and their synthetic …

Delta 9 tetrahydrocannabinol (THC), the main component of cannabis, has adverse effects
on the cardiovascular system, but whether concomitant ethanol (EtOH) and aging modulate …

Introduction Cannabidiol (CBD) is the primary non-psychoactive chemical derived from
Cannabis Sativa, and its growing popularity is due to its potential therapeutic properties …